Blogroll

SoftBank Group Corp said it sees a loss of around 700 billion yen ($6.6 billion) for the year ended March on the portion of its WeWork investment held outside the Vision Fund, as the virus compounds woes at one of the firm's biggest bets.

State-controlled telecoms group Swisscom AG said on Thursday that the rollout of its new fifth-generation (5G) mobile technology was getting stalled due to the governments' resistance to installing upgraded antennas.

Japan's Nintendo Co Ltd is expected to extend its decade-high earnings streak when it reports fourth-quarter results next week, powered by the hit Switch console which is expanding its reach among locked-down consumers.

The top U.S. infectious disease official said Gilead Sciences Inc's experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early clinical trial results on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.

Amazon.com Inc has bought cameras to take temperatures of workers during the coronavirus pandemic from a firm the United States blacklisted over allegations it helped China detain and monitor Uighurs and other Muslim minorities, three people familiar with the matter told Reuters.

New clinical data on Gilead Sciences Inc's experimental antiviral drug remdesivir has raised hopes it might be an effective treatment for the novel coronavirus that has infected more than 3 million people and killed over 225,000 worldwide.

U.S. drug regulators may announce their decision allowing emergency use of Gilead Science Inc's experimental coronavirus drug remdesivir as soon as Wednesday, the New York Times reported, citing an unnamed senior administration official.

U.S. President Donald Trump on Wednesday greeted as good news reports that a Gilead Sciences Inc experimental antiviral drug might help fight the coronavirus, and infectious disease official Anthony Fauci said data shows it appears to help patients hospitalized with COVID-19.

A top World Health Organization official declined comment on Wednesday on reports that Gilead Science's remdesivir could help treat COVID-19, the respiratory disease caused by the novel coronavirus, but said that further data was needed.

South Korea reported on Thursday no new domestic coronavirus cases for the first time since its Feb. 29 peak, the Korea Centers for Disease Control and Prevention (KCDC) said.

Facebook Inc beat analysts' estimates for quarterly revenue on Wednesday and said it has seen "signs of stability" for sales in April after a plunge in March, in yet another signal that tech giants may weather the coronavirus-induced economic collapse better than other sectors.

Yemen has reported its first two deaths from the novel coronavirus, its health minister told Yemen TV late on Wednesday.

SoftBank Group Corp said it sees a loss of around 700 billion yen ($6.6 billion) in the year ending March on the portion of its WeWork investment held outside the Vision Fund, extending the group's expected net loss to 900 billion yen.

China reported four new coronavirus cases for April 29, down from 22 a day earlier, data from the country's health authority showed.

Mexico's health ministry on Wednesday reported 1,047 new confirmed cases of coronavirus infection and 163 additional fatalities, bringing the total in the country to 17,799 cases and 1,732 deaths.

Confirmed cases of coronavirus infection in Panama reached 6,378 on Wednesday, a rise of 178 from the previous day, and deaths climbed by two to 178, the health ministry said.

A coronavirus outbreak in Australia's remote southern island state of Tasmania likely originated from the Ruby Princess cruise ship, a government report published on Thursday concluded, as the national death toll rose to 91.

Doctors caring for COVID-19 patients at hospitals across the United States have taken up temporary residence in donated recreational vehicles, parked outside their homes, as a way to keep them near to their families yet isolated.

The Trump administration is planning to speed up development of a coronavirus vaccine with the goal of having 100 million doses ready by the end of 2020, a senior administration official said on Wednesday.

Britain plans to test a randomly chosen group of 100,000 people for COVID-19 as part of its efforts to understand infection rates better before loosening restrictions on the public, its health ministry said on Thursday.